Company intelligence / Profile preview
Affilogic
Nantes, Franceaffilogic.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Recent publication in Nature Scientific Report by partner Bracco Imaging on HER-2 targeting Nanofitins as diagnostic tools; New publication in Biomolecules on multispecific checkpoint inhibitor Nanofitin with tumor accumulation properties and anti-tumor activity in mice[1]
- Therapeutic areas
- OncologyGastroenterologyNeurologyInfectious Diseases
- Modalities
- Nanofitins® (antibody-mimetic binding proteins)
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
03
Partnerships
Bracco Imagingworldwide pharmaceutical industry leaders[1][2]
Beyond the preview
Go deeper on Affilogic.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Affilogic.